LeserbriefOpen Access · CC BY 4.0
Antibody-drug conjugates for precision oncology in cholangiocarcinoma
EXCLI Journal · 14.11.2025 · 24 · 1594-1598
DOI: 10.17179/excli2025-8952 ↗Kurz gefasst
Leserbrief in der Zeitschrift EXCLI Journal, online erschienen am 14.11.2025. Verfasst von Parteek Prasher und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Petroleum & Energy Studies (UPES), Dehradun, 248007, India. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Chemistry, University of Petroleum & Energy Studies (UPES), Dehradun, 248007, India.
- Department of Chemistry, Uttaranchal University, Dehradun, 248007, India.
Zitieren
APA
Prasher, P., & Sharma, M. (2025). Antibody-drug conjugates for precision oncology in cholangiocarcinoma. EXCLI Journal, 24, 1594-1598. https://doi.org/10.17179/excli2025-8952
Vancouver
Prasher P, Sharma M. Antibody-drug conjugates for precision oncology in cholangiocarcinoma. EXCLI Journal. 2025;24:1594-1598. doi:10.17179/excli2025-8952
BibTeX
@article{Prasher2025,
author = {Prasher, Parteek and Sharma, Mousmee},
title = {Antibody-drug conjugates for precision oncology in cholangiocarcinoma},
journal = {EXCLI Journal},
year = {2025},
volume = {24},
pages = {1594--1598},
doi = {10.17179/excli2025-8952}
}
EUVIMED